Irini Sereti

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. pmc In vivo expansion of CD4CD45RO-CD25 T cells expressing foxP3 in IL-2-treated HIV-infected patients
    Irini Sereti
    National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA
    J Clin Invest 115:1839-47. 2005
  2. ncbi request reprint CD4+ T cell responses to interleukin-2 administration in HIV-infected patients are directly related to the baseline level of immune activation
    Irini Sereti
    National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
    J Infect Dis 196:677-83. 2007
  3. ncbi request reprint IL-2-induced CD4+ T-cell expansion in HIV-infected patients is associated with long-term decreases in T-cell proliferation
    Irini Sereti
    Clinical and Molecular Retrovirology Section, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
    Blood 104:775-80. 2004
  4. pmc IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection
    Irini Sereti
    National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892, USA
    Blood 113:6304-14. 2009
  5. doi request reprint Inferiority of IL-2 alone versus IL-2 with HAART in maintaining CD4 T cell counts during HAART interruption: a randomized controlled trial
    Brian O Porter
    National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20982, USA
    AIDS 23:203-12. 2009
  6. pmc The effect of leflunomide on cycling and activation of T-cells in HIV-1-infected participants
    Sarah W Read
    Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
    PLoS ONE 5:e11937. 2010
  7. pmc Induction of prolonged survival of CD4+ T lymphocytes by intermittent IL-2 therapy in HIV-infected patients
    Joseph A Kovacs
    Critical Care Medicine Department, Warren G Magnuson Clinical Center, NIH, Bethesda, Maryland, USA
    J Clin Invest 115:2139-48. 2005
  8. pmc Naïve T-cell dynamics in human immunodeficiency virus type 1 infection: effects of highly active antiretroviral therapy provide insights into the mechanisms of naive T-cell depletion
    Michele Di Mascio
    National Institute of Allergy and Infectious Diseases, National Institutes of Health, 6700 B Rockledge Drive, MSC 7609, Bethesda, MD 20892, USA
    J Virol 80:2665-74. 2006
  9. pmc CD4 T cell survival after intermittent interleukin-2 therapy is predictive of an increase in the CD4 T cell count of HIV-infected patients
    Sarah W Read
    Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, USA
    J Infect Dis 198:843-50. 2008
  10. pmc Interleukin-2 cycling causes transient increases in high-sensitivity C-reactive protein and D-dimer that are not associated with plasma HIV-RNA levels
    Brian O Porter
    National Institute of Allergy and Infectious Diseases, National Institutes of Health, 10 Center Drive, Bethesda, MD 20892, USA
    AIDS 23:2015-9. 2009

Detail Information

Publications49

  1. pmc In vivo expansion of CD4CD45RO-CD25 T cells expressing foxP3 in IL-2-treated HIV-infected patients
    Irini Sereti
    National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA
    J Clin Invest 115:1839-47. 2005
    ..These CD4CD25 cytokine-expanded naive cells, distinct from antigen-triggered cells and Tregs, play a role in the maintenance of a state of low turnover and sustained expansion of the CD4 T cell pool...
  2. ncbi request reprint CD4+ T cell responses to interleukin-2 administration in HIV-infected patients are directly related to the baseline level of immune activation
    Irini Sereti
    National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
    J Infect Dis 196:677-83. 2007
    ..Intermittent interleukin (IL)-2 administration to human immunodeficiency virus (HIV)-infected patients leads to CD4(+) T cell expansions. The factors potentially affecting these expansions were investigated in the present study...
  3. ncbi request reprint IL-2-induced CD4+ T-cell expansion in HIV-infected patients is associated with long-term decreases in T-cell proliferation
    Irini Sereti
    Clinical and Molecular Retrovirology Section, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
    Blood 104:775-80. 2004
    ..These data suggest that decreased T-cell proliferation is central in the CD4+ T-cell expansions induced by IL-2...
  4. pmc IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection
    Irini Sereti
    National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892, USA
    Blood 113:6304-14. 2009
    ..Thus, rhIL-7 has a biologic and toxicity profile suggesting a potential for therapeutic trials in HIV infection and other settings of lymphopenia. This clinical trial has been registered at http://www.clinicaltrials.gov under NCT0099671...
  5. doi request reprint Inferiority of IL-2 alone versus IL-2 with HAART in maintaining CD4 T cell counts during HAART interruption: a randomized controlled trial
    Brian O Porter
    National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20982, USA
    AIDS 23:203-12. 2009
    ..To evaluate whether interleukin (IL)-2 in patients with chronic HIV infection can maintain CD4 T cell counts during 6 months of HAART interruption...
  6. pmc The effect of leflunomide on cycling and activation of T-cells in HIV-1-infected participants
    Sarah W Read
    Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
    PLoS ONE 5:e11937. 2010
    ..Immunomodulatory agents that decrease immune activation may be useful in the treatment of HIV-1 infection...
  7. pmc Induction of prolonged survival of CD4+ T lymphocytes by intermittent IL-2 therapy in HIV-infected patients
    Joseph A Kovacs
    Critical Care Medicine Department, Warren G Magnuson Clinical Center, NIH, Bethesda, Maryland, USA
    J Clin Invest 115:2139-48. 2005
    ....
  8. pmc Naïve T-cell dynamics in human immunodeficiency virus type 1 infection: effects of highly active antiretroviral therapy provide insights into the mechanisms of naive T-cell depletion
    Michele Di Mascio
    National Institute of Allergy and Infectious Diseases, National Institutes of Health, 6700 B Rockledge Drive, MSC 7609, Bethesda, MD 20892, USA
    J Virol 80:2665-74. 2006
    ..These observations are consistent with a mathematical model where the HIV-1-induced increase in proliferation of naïve T cells is mostly explained by a faster recruitment into memory cells...
  9. pmc CD4 T cell survival after intermittent interleukin-2 therapy is predictive of an increase in the CD4 T cell count of HIV-infected patients
    Sarah W Read
    Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, USA
    J Infect Dis 198:843-50. 2008
    ..Thus, an increase in the survival of CD4 T cells appears to be the critical mechanism leading to sustained increases in the CD4 cell counts of HIV-infected patients receiving intermittent IL-2 therapy...
  10. pmc Interleukin-2 cycling causes transient increases in high-sensitivity C-reactive protein and D-dimer that are not associated with plasma HIV-RNA levels
    Brian O Porter
    National Institute of Allergy and Infectious Diseases, National Institutes of Health, 10 Center Drive, Bethesda, MD 20892, USA
    AIDS 23:2015-9. 2009
    ..To determine the effects of interleukin (IL)-2 treatment on inflammatory and thrombotic biomarkers in chronically HIV-infected adults receiving antiretroviral therapy...
  11. ncbi request reprint Incomplete CD4 T cell recovery in HIV-1 infection after 12 months of highly active antiretroviral therapy is associated with ongoing increased CD4 T cell activation and turnover
    Kara B Anthony
    Clinical and Molecular Retrovirology Section, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases NIH, 10 Center Drive, Building 10, Bethesda, MD 20892, USA
    J Acquir Immune Defic Syndr 33:125-33. 2003
    ..These data suggest that immune activation is central to CD4 cell depletion in HIV infection and immune reconstitution with HAART...
  12. ncbi request reprint A randomized, double-blinded, placebo-controlled trial of intermittent administration of interleukin-2 and prednisone in subjects infected with human immunodeficiency virus
    Jorge A Tavel
    Office of the Clinical Director, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892, US
    J Infect Dis 188:531-6. 2003
    ....
  13. ncbi request reprint Decreased CD127 expression on T Cells in HIV-1-infected adults receiving antiretroviral therapy with or without intermittent IL-2 therapy
    Sarah W Read
    National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
    J Acquir Immune Defic Syndr 42:537-44. 2006
    ..We evaluated the IL-7/IL-7Ralpha system in a large cohort of HIV-infected patients, including a subset treated with intermittent IL-2...
  14. ncbi request reprint Interruption of antiretroviral therapy blunts but does not abrogate CD4 T-cell responses to interleukin-2 administration in HIV infected patients
    Chris E Keh
    National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA
    AIDS 20:361-9. 2006
    ..IL-2 is under evaluation in antiretroviral therapy (ART) interruption studies, but it is unclear how the emergence of viremia may affect CD4 expansions...
  15. pmc d-Dimer and CRP levels are elevated prior to antiretroviral treatment in patients who develop IRIS
    Brian O Porter
    National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
    Clin Immunol 136:42-50. 2010
    ..66 mg /L, p=0.037; CRP: 0.74 mg/L versus 0.39 mg/L, p=0.022), while d-dimer was higher in unmasking cases at IRIS onset (2.04 mg/L versus 0.36 mg /L, p=0.05). These biomarkers may be useful in identifying patients at risk for IRIS...
  16. pmc Elevated frequencies of highly activated CD4+ T cells in HIV+ patients developing immune reconstitution inflammatory syndrome
    Lis R V Antonelli
    Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
    Blood 116:3818-27. 2010
    ..These studies are registered online at http://clinicaltrials.gov as NCT00557570 and NCT00286767...
  17. ncbi request reprint BAY 50-4798, a novel, high-affinity receptor-specific recombinant interleukin-2 analog, induces dose-dependent increases in CD25 expression and proliferation among unstimulated, human peripheral blood mononuclear cells in vitro
    Lynn Matthews
    Clinical and Molecular Retrovirology Section, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
    Clin Immunol 113:248-55. 2004
    ..These data suggest that BAY 50-4798 can induce proliferation of unstimulated T cells but loss of T cell selectivity and induction of pro-inflammatory cytokines occur at concentrations exerting the highest biologic activity...
  18. pmc Selective expansion of polyfunctional pathogen-specific CD4(+) T cells in HIV-1-infected patients with immune reconstitution inflammatory syndrome
    Yolanda D Mahnke
    Immunotechnology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
    Blood 119:3105-12. 2012
    ..These studies were registered at www.clinical-trials.gov as NCT00557570 and NCT00286767...
  19. ncbi request reprint Long-term effects of intermittent interleukin 2 therapy in patients with HIV infection: characterization of a novel subset of CD4(+)/CD25(+) T cells
    Irini Sereti
    Clinical and Molecular Retrovirology Section, Labotratory of Immunoregulation, National Institute of Allergy and Infectious Diseases NIH, Building 10, Room 11S 231, 10 Center Drive, Bethesda, MD 20892, USA
    Blood 100:2159-67. 2002
    ..Thus, intermittent administration of IL-2 in HIV(+) patients leads to preferential expansion of a unique subset of CD4(+) T cells that may represent a critical population in T-cell homeostasis...
  20. pmc IL-7 induces expression and activation of integrin α4β7 promoting naive T-cell homing to the intestinal mucosa
    Raffaello Cimbro
    Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
    Blood 120:2610-9. 2012
    ....
  21. pmc Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection
    Emily S Ford
    National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA
    AIDS 24:1509-17. 2010
    ..In this retrospective, case-control study of HIV-infected individuals, we investigated the association of traditional cardiac risk factors, HIV-related disease, and inflammation with CVD events...
  22. pmc Decreases in IL-7 levels during antiretroviral treatment of HIV infection suggest a primary mechanism of receptor-mediated clearance
    Jessica N Hodge
    Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases NIAID, Bethesda, MD, USA
    Blood 118:3244-53. 2011
    ..These data suggest that T-cell restoration after ART in HIV infection is driven predominantly by CD127(+) cells and that decreases of serum IL-7 can be largely explained by improved CD127-mediated clearance...
  23. pmc Decreased interleukin 7 responsiveness of T lymphocytes in patients with idiopathic CD4 lymphopenia
    Camille E Puronen
    Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA
    J Infect Dis 205:1382-90. 2012
    ....
  24. pmc HIV-1 viruses detected during episodic blips following interleukin-7 administration are similar to the viruses present before and after interleukin-7 therapy
    Hiromi Imamichi
    Clinical and Molecular Retrovirology Section, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, USA
    AIDS 25:159-64. 2011
    ..However, a proportion of patients treated with recombinant human IL-7 experience transient increases in plasma HIV-RNA ('blips'), possibly reflecting 'purging' of a quiescent reservoir that provides a barrier to viral eradication...
  25. doi request reprint Markers of endothelial dysfunction, coagulation and tissue fibrosis independently predict venous thromboembolism in HIV
    Laura W Musselwhite
    National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, USA
    AIDS 25:787-95. 2011
    ..We investigated the relationship between venous thrombosis and HIV-related characteristics, traditional risk factors of hypercoagulability, and pre-event levels of biomarkers...
  26. pmc CD4+ T cells, including Th17 and cycling subsets, are intact in the gut mucosa of HIV-1-infected long-term nonprogressors
    Emily J Ciccone
    Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, NIH, 10 Center Drive, Bethesda, MD 20892, USA
    J Virol 85:5880-8. 2011
    ....
  27. pmc Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors
    Dimitrios I Zonios
    Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
    Blood 112:287-94. 2008
    ..CD8 T lymphocytopenia (< 180/mm(3)) and the degree of CD4 T cell activation (measured by HLA-DR expression) at presentation were associated with adverse outcome (opportunistic infection-related death; P = .003 and .02, respectively)...
  28. doi request reprint Prevalence of Strongyloides stercoralis in an urban US AIDS cohort
    Linda Nabha
    National Institute of Allergy and Infectious Diseases NIAID, National Institutes of Health NIH, Bethesda, MD 20892, USA
    Pathog Glob Health 106:238-44. 2012
    ..We monitored our cohort for possible cases of dissemination or immune reconstitution inflammatory syndrome after antiretroviral therapy (ART) initiation...
  29. ncbi request reprint The common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligands
    Audrey L Kinter
    Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
    J Immunol 181:6738-46. 2008
    ....
  30. pmc Th1-driven immune reconstitution disease in Mycobacterium avium-infected mice
    Daniel L Barber
    Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 50 South Drive, Bethesda, MD 20892, USA
    Blood 116:3485-93. 2010
    ..Instead, our findings suggest that mycobacterial-associated IRIS results from a heightened sensitivity of infected lymphopenic hosts to the detrimental effects of Ag-driven CD4 T-cell responses...
  31. pmc Evidence for translocation of microbial products in patients with idiopathic CD4 lymphocytopenia
    Philip I Lee
    National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA
    J Infect Dis 199:1664-70. 2009
    ..These findings suggest a potential association of translocation of microbial products with perturbed CD4 T cell homeostasis in individuals with CD4 lymphopenic states other than HIV infection...
  32. pmc Peptide library-based evaluation of T-cell receptor breadth detects defects in global and regulatory activation in human immunologic diseases
    John S Barber
    Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
    Proc Natl Acad Sci U S A 110:8164-9. 2013
    ..These findings provide unique insight into the pathophysiology and functional consequences of abnormal T-cell repertoires and into differentiation of human naive T-cells...
  33. pmc The effect of intermittent IL-2 therapy on CD4 T cells in the gut in HIV-1-infected patients
    Sarah W Read
    Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
    J Acquir Immune Defic Syndr 56:340-3. 2011
    ..Although IL-2 administration leads to expansion of peripheral blood CD4+ T cells, there is no alteration in the proportion or activation of CD4+ T cells in the gut mucosa...
  34. pmc Lack of compartmentalization of HIV-1 quasispecies between the gut and peripheral blood compartments
    Hiromi Imamichi
    Clinical and Molecular Retrovirology Section, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
    J Infect Dis 204:309-14. 2011
    ....
  35. pmc Cerebrospinal fluid HIV-1 compartmentalization in a patient with AIDS and acute varicella-zoster virus meningomyeloradiculitis
    E Liana Falcone
    Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892 1684, USA
    Clin Infect Dis 57:e135-42. 2013
    ..Prolonged antiviral therapy for both VZV and HIV type 1 was associated with partial resolution. ..
  36. pmc Comprehensive analysis of unique cases with extraordinary control over HIV replication
    Daniel Mendoza
    Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 10 Center Drive, Bethesda, MD 20892, USA
    Blood 119:4645-55. 2012
    ..Additional insight into the full spectrum of immune-mediated suppression over HIV replication may enhance our understanding of the associated mechanisms, which should inform the design of efficacious HIV vaccines and immunotherapies...
  37. pmc Immune reconstitution inflammatory syndrome: the trouble with immunity when you had none
    Daniel L Barber
    Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rm 6146, 50 South Drive, Bethesda, Maryland, 20892, USA
    Nat Rev Microbiol 10:150-6. 2012
    ....
  38. ncbi request reprint Cutting edge: L-selectin (CD62L) expression distinguishes small resting memory CD4+ T cells that preferentially respond to recall antigen
    Richard L Hengel
    Division of Infectious Diseases, Department of Medicine, Georgetown University School of Medicine, Washington, DC 20053, USA
    J Immunol 170:28-32. 2003
    ..These findings suggest that CD62L expression facilitates immune surveillance by programming CD4+ T cell blood and lymph node recirculation, irrespective of naive or memory CD4+ T cell phenotype...
  39. pmc IL-15 acts as a potent inducer of CD4(+)CD25(hi) cells expressing FOXP3
    Hiromi Imamichi
    Laboratory of Molecular Retrovirology, Clinical Services Program, SAIC Frederick Inc, NCI Frederick, Frederick, MD 21702, USA
    Eur J Immunol 38:1621-30. 2008
    ..This study has provided further insights into the pleiotropic nature of IL-15 beyond the regulation of CD8(+) T cells...
  40. pmc Differential effects of HIV viral load and CD4 count on proliferation of naive and memory CD4 and CD8 T lymphocytes
    Sharat Srinivasula
    Biostatistics Research Branch, SAIC Frederick Inc, NCI Frederick, Frederick, MD, USA
    Blood 118:262-70. 2011
    ..Microbial translocation does not appear to play an important role in this proliferation...
  41. doi request reprint Role of IL-6 in Mycobacterium avium-Associated Immune Reconstitution Inflammatory Syndrome
    Daniel L Barber
    T Lymphocyte Biology Unit, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892
    J Immunol 192:676-82. 2014
    ....
  42. pmc Biomarkers in immune reconstitution inflammatory syndrome: signals from pathogenesis
    Irini Sereti
    Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA
    Curr Opin HIV AIDS 5:504-10. 2010
    ..New insights into the pathogenesis of IRIS may help identify biomarkers that could be useful in predicting or diagnosing IRIS...
  43. pmc Immunopathogenesis of asymptomatic chronic HIV Infection: the calm before the storm
    Emily S Ford
    Clinical and Molecular Retrovirology Section, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA
    Curr Opin HIV AIDS 4:206-14. 2009
    ..This review addresses the factors that influence immune activation and may thus determine the rate of disease progression during the asymptomatic period of HIV...
  44. pmc Effects of lymphocyte isolation and timing of processing on detection of CD127 expression on T cells in human immunodeficiency virus-infected patients
    Jeanette Higgins
    AIDS Monitoring Laboratory, Clinical Services Program, Science Applications International Corp, Frederick, Maryland, USA
    Clin Diagn Lab Immunol 12:228-30. 2005
    ..These observations should be considered in the interpretation of functional studies and the planning of multicenter clinical trials...
  45. pmc Increased peripheral expansion of naive CD4+ T cells in vivo after IL-2 treatment of patients with HIV infection
    Ven Natarajan
    Science Applications International Corporation Frederick, Inc, Frederick, MD 21702, USA
    Proc Natl Acad Sci U S A 99:10712-7. 2002
    ....
  46. ncbi request reprint Graves' disease after interleukin-2 therapy in a patient with human immunodeficiency virus infection
    Camilo Jimenez
    Joint Endocrinology, Diabetes and Metabolism Fellowship at Baylor College of Medicine The University of Texas M D Anderson Cancer Center, Houston 77030, USA
    Thyroid 14:1097-102. 2004
    ..From a practical standpoint, we propose that patients who have received or are receiving treatment with IL-2 who show signs of hyperthyroidism need to be carefully evaluated for GD...
  47. ncbi request reprint Delayed sample processing leads to marked decreases in measured plasma IL-7 levels
    Sarah W Read
    J Acquir Immune Defic Syndr 42:511-2. 2006
  48. pmc Effects of delays in peripheral blood processing, including cryopreservation, on detection of CD31 expression on naive CD4 T cells
    Jeanette Higgins
    AIDS Monitoring Laboratory, Clinical Services Program, SAIC Frederick, Inc, NCI Frederick, Frederick, Maryland 21702, USA
    Clin Vaccine Immunol 15:1141-3. 2008
    ..These observations should be considered in the planning of multicenter clinical trials and in the interpretation of the results of functional studies...
  49. ncbi request reprint HIV infection and the gut: scarred for life?
    Sarah W Read
    J Infect Dis 198:453-5. 2008